Rocket


Overview
Financials
News + Filings

 
 

COGNITION THERAPEUTICS INC Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19
Revenues13.315.5
            Revenue growth-14.1% 
Cost of goods sold17.417.8
Gross profit-4.1-2.4
            Gross margin-31.1%-15.3%
General and administrative4.53.5
EBIT-17.4-17.8
            EBIT margin-131.1%-115.3%
Pre-tax income-7.8-4.8
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-12.1-8.8
            Net margin-90.9%-56.7%
 
Diluted EPS($7.35)($5.77)
Shares outstanding (diluted)1.61.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy